Clin2
NCT04642352Possibly a fitRecruiting

Nerve block injections for long-lasting nerve cough

Cough

Part of Lungs & breathing clinical trials.

This trial studies an office-based injection to calm a specific nerve in the neck to treat chronic cough that seems to come from nerve irritation (“neurogenic/sensory neuropathic” cough). It may help people whose cough has lasted at least 8 weeks and continues despite standard treatments for common cough causes.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You can speak and understand English and provide your own consent.
  • Your cough has lasted 8 weeks or longer, and it seems triggered like nerve irritation (for example by smells, temperature changes, tickling, or throat irritation).
  • Your cough has not improved after standard treatments for common causes: reflux, asthma, and allergies/upper airway problems.
  • You must NOT have a different known cause for cough (such as reflux disease, asthma, allergic rhinitis, or COPD) as the main reason.
  • You must not start new “nerve medicine” at the time of the injection (but stable doses of gabapentin or amitriptyline may be allowed).
  • You cannot have had a Nissen fundoplication within the last year, and you cannot have smoked in the last 5 years.
  • You need to be able to safely receive bupivacaine and Kenalog-40 (no allergy to these medicines).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07288528Not yet recruiting· Phase 4
Testing nerve blockers and cough control for chronic cough

This study tests two treatments—nerve blockers and a cough control therapy—for people with chronic cough that hasn't improved with standard treatments or has no clear cause. The goal is to find better ways to reduce coughing and improve quality of life.

Calgary, Alberta
NCT05273190Recruiting
Using gentle larynx stimulation to treat chronic unexplained cough

This study tests whether stimulating the larynx (voice box area) can reduce cough that has lasted more than 8 weeks. It may help people whose cough is not clearly explained by infections, lung diseases, or other common causes.

Minneapolis, Minnesota
NCT05665244Recruiting
Cryotherapy for long-lasting cough from nerve signals

This trial tests a cold-treatment procedure (cryotherapy) to treat a stubborn cough caused by nerve signaling (not infections or common allergy/acid problems). It may help people whose cough has lasted at least 8 weeks and who have already tried to rule out other causes.

Dallas, Texas
NCT06634823Recruiting· Early Phase 1
Steroid injection for chronic cough study

This study tests whether a steroid shot into the neck muscles can help people with a long-lasting, unexplained cough. It is for adults who have tried other treatments and still cough.

Charleston, South Carolina
NCT07488598Recruiting
Behavioral therapy for hard-to-treat chronic cough

This trial tests a behavioral therapy for people whose chronic cough (lasting more than 8 weeks) hasn't improved with usual treatments like asthma or reflux medicine. You may join if your cough is triggered by things like talking, laughing, cold air, or irritants, and you have throat symptoms like irritation or hoarseness.

Asyut
NCT07671924Recruiting· Phase 2
Testing nalbuphine extended-release for chronic cough

This trial tests whether an extended-release medication called nalbuphine can reduce coughing in people with chronic cough that hasn't improved with other treatments. You may be eligible if you've had a persistent cough for at least a year and have already tried treatments for conditions that could cause it.

Ajax

Hear when a new Cough trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.